The Basics
What is Latanoprost?
Used to treat glaucoma and ocular hypertension.
Brand names for Latanoprost
Xalatan
How Latanoprost is classified
Antiglaucoma Agents, Prostaglandins
Latanoprost During Pregnancy
Latanoprost pregnancy category
Category CNote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.
What we know about taking Latanoprost while pregnant
N/A
Taking Latanoprost While Breastfeeding
What are recommendations for lactation if you're taking Latanoprost?
No information is available on the use of latanoprost during breastfeeding. Because of its short half-life it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Maternal / infant drug levels
No information is available on the use of latanoprost during breastfeeding. Because of its short half-life it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Possible effects of Latanoprost on milk supply
Relevant published information was not found as of the revision date.
Possible alternatives to Latanoprost
None listed
List of References
Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/1. Larsen GK. Iatrogenic breast discharge with isotretinoin. Arch Dermatol. 1985;121:450-1. PMID: 3856419
2. Atzenhoffer M, Pierre S, Bellet F et al. Gynecomastia and galactorrhea: Unlabeled adverse drug reactions of retinoids used in dermatology. Drug Safety. 2018;41:1198-9. Abstract. DOI: doi:10.1007/s40264-018-0719-2
Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.
